These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32031980)

  • 1. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2.
    Wihastuti TA; Amiruddin R; Cesa FY; Alkaf AI; Setiawan M; Heriansyah T
    J Basic Clin Physiol Pharmacol; 2020 Feb; 30(6):. PubMed ID: 32031980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in Vasa Vasorum Angiogenesis by Lp-PLA2 Selective Inhibitor Through The HIF-1α and VEGF Expression Under Dyslipidemic Conditions in Atherosclerosis Pathogenesis.
    Heriansyah T; Nafisatuzzamrudah N; Aini FN; Ridwan M; Primardhika RF; Wijayanti M; Bekti RS; Wihastuti TA
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):114-119. PubMed ID: 30394217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasa vasorum anti-angiogenesis through H₂O₂, HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol-diet-given Rattus norvegicus Wistar strain.
    Wihastuti TA; Sargowo D; Tjokroprawiro A; Permatasari N; Widodo MA; Soeharto S
    Vasc Health Risk Manag; 2014; 10():523-31. PubMed ID: 25187725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model.
    Xu X; Mao W; Chai Y; Dai J; Chen Q; Wang L; Zhuang Q; Pan Y; Chen M; Ni G; Huang Z
    J Atheroscler Thromb; 2015; 22(10):1100-12. PubMed ID: 26016418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reduction of aorta histopathological images through inhibition of reactive oxygen species formation in hypercholesterolemia rattus norvegicus treated with polysaccharide peptide of Ganoderma lucidum.
    Andri Wihastuti T; Sargowo D; Heriansyah T; Eka Aziza Y; Puspitarini D; Nur Iwana A; Astrida Evitasari L
    Iran J Basic Med Sci; 2015 May; 18(5):514-9. PubMed ID: 26124939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.
    Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN
    Ann Med; 2017 Dec; 49(8):661-677. PubMed ID: 28797175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice.
    Mollmark JI; Park AJ; Kim J; Wang TZ; Katzenell S; Shipman SL; Zagorchev LG; Simons M; Mulligan-Kehoe MJ
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2644-51. PubMed ID: 22982464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice.
    Veerman KJ; Venegas-Pino DE; Shi Y; Khan MI; Gerstein HC; Werstuck GH
    Atherosclerosis; 2013 Apr; 227(2):250-8. PubMed ID: 23411040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysaccharide peptide (PsP) G
    Heriansyah T; Nurwidyaningtyas W; Sargowo D; Tjahjono CT; Wihastuti TA
    Vasc Health Risk Manag; 2019; 15():419-427. PubMed ID: 31632046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.
    Sedding DG; Boyle EC; Demandt JAF; Sluimer JC; Dutzmann J; Haverich A; Bauersachs J
    Front Immunol; 2018; 9():706. PubMed ID: 29719532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasa vasorum in atherosclerosis and clinical significance.
    Xu J; Lu X; Shi GP
    Int J Mol Sci; 2015 May; 16(5):11574-608. PubMed ID: 26006236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study].
    Chen J; Cai HW; Miao J; Xu XM; Mao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance adipocyte-derived exosomes aggravate atherosclerosis by increasing vasa vasorum angiogenesis in diabetic ApoE
    Wang F; Chen FF; Shang YY; Li Y; Wang ZH; Han L; Li YH; Zhang L; Ti Y; Zhang W; Zhong M
    Int J Cardiol; 2018 Aug; 265():181-187. PubMed ID: 29685689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting vasa vasorum dysfunction to prevent atherosclerosis.
    Boyle EC; Sedding DG; Haverich A
    Vascul Pharmacol; 2017 Sep; 96-98():5-10. PubMed ID: 28830735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis.
    Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH
    Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
    Herrmann J; Best PJ; Ritman EL; Holmes DR; Lerman LO; Lerman A
    J Am Coll Cardiol; 2002 May; 39(9):1555-61. PubMed ID: 11985922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Microvascular Dysfunction: Is the Vasa Vasorum a "Missing Link" in Insulin Resistance and Atherosclerosis.
    Owusu J; Barrett E
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia.
    Gössl M; Herrmann J; Tang H; Versari D; Galili O; Mannheim D; Rajkumar SV; Lerman LO; Lerman A
    Basic Res Cardiol; 2009 Nov; 104(6):695-706. PubMed ID: 19458984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vasa vasorum in diseased and nondiseased arteries.
    Mulligan-Kehoe MJ
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H295-305. PubMed ID: 19940078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effects of polysaccharide peptides (PsP) of
    Wihastuti TA; Heriansyah T
    Heart Int; 2017; 12(1):e1-e7. PubMed ID: 29114382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.